HemaCare is pleased to announce the publication of their latest article [1] in the current issue of BioProcess International.
The piece, entitled “The Cell Therapy Industry Needs High-Quality Healthy-Donor Material”, gives readers expert insight into the growing demand for cell therapy starting material, and how that demand is impacting suppliers.